Skip to main content

JW Asset Management, LLC

SEC CIK
0001549738
Latest filing
Aug 7, 2026

The latest 13F from JW Asset Management, LLC covers Q2 2026 (filed Aug 7, 2026): 21 long positions worth $319.9M. The top 10 holdings make up 95.6% of the portfolio, and the largest is Establishment Labs Holdings Inc. (ESTA) at 72.2%. Livermore has 23 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
5
Est. +$6.26M
Added
2
Est. +$3.36M
Reduced
6
Est. −$33.5M
Sold out
3
Est. −$13.5M

Top 5 holdings

Share of this quarter's portfolio value

  1. ESTAEstablishment Labs Holdings Inc.
    72.2%$231.1MHistory
  2. SNDKSandisk Corp
    5.6%$17.8MHistory
  3. COCOVita Coco Company, Inc.
    4.5%$14.5MHistory
  4. CPRXCatalyst Pharmaceuticals, Inc.
    3.8%$12.2MHistory
  5. MUMicron Technology Inc
    2.5%$8.08MHistory

Share of portfolio

Top 5 holdings and the other 16 positions, by share of portfolio value

  1. ESTA72.2%
  2. SNDK5.6%
  3. COCO4.5%
  4. CPRX3.8%
  5. MU2.5%
  6. Other 16 positions11.3%

Biggest buys

New and added positions, by estimated amount bought

  1. SNDKSandisk Corp
    +$2.98MAddedHistory
  2. TVTXTravere Therapeutics, Inc.
    +$1.70MNewHistory
  3. DELLDell Technologies Inc.
    +$1.51MNewHistory
  4. LGNDLigand Pharmaceuticals Inc
    +$1.26MNewHistory
  5. MRVLMarvell Technology, Inc.
    +$953.2KNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. SNDKSandisk Corp
    +3.86 pp1.7% → 5.6%History
  2. TVTXTravere Therapeutics, Inc.
    +0.53 pp0.0% → 0.5%History
  3. DELLDell Technologies Inc.
    +0.47 pp0.0% → 0.5%History
  4. LGNDLigand Pharmaceuticals Inc
    +0.40 pp0.0% → 0.4%History
  5. MRVLMarvell Technology, Inc.
    +0.30 pp0.0% → 0.3%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. ESTAEstablishment Labs Holdings Inc.
    −$31.6MReducedHistory
  2. GOOGAlphabet Inc.
    −$7.90MSold outHistory
  3. METAMeta Platforms, Inc.
    −$4.98MSold outHistory
  4. IRENIREN Ltd
    −$914.6KReducedHistory
  5. Invesco QQQ Trust Series I46090E103
    −$577.2KSold out

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. GOOGAlphabet Inc.
    −3.24 pp3.2% → 0.0%History
  2. METAMeta Platforms, Inc.
    −2.04 pp2.0% → 0.0%History
  3. IDRIdaho Strategic Resources, Inc.
    −0.44 pp1.9% → 1.4%History
  4. ONONOn Holding AG
    −0.35 pp1.2% → 0.8%History
  5. IRENIREN Ltd
    −0.25 pp2.3% → 2.1%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$319.9M
+$76.4M (+31.4%) vs. prior quarter
Positions
21
+2 vs. prior quarter
Top 10 concentration
95.6%
Top 10 as share of value
Turnover
3.4%
Q2 2026, one quarter
Average holding period
17.9 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $427.5M (Q2 2021)

Q1 2021: $347.6MQ2 2021: $427.5MQ3 2021: $331.6MQ4 2021: $301.8MQ1 2022: $290.3MQ2 2022: $183.3MQ3 2022: $185.7MQ4 2022: $243.1MQ1 2023: $260.6MQ2 2023: $274.8MQ3 2023: $230.9MQ4 2023: $175.2MQ1 2024: $273.7MQ2 2024: $242.7MQ3 2024: $221.5MQ4 2024: $210.4MQ1 2025: $176.6MQ2 2025: $202.9MQ3 2025: $208.4MQ4 2025: $307.2MQ1 2026: $243.5MQ2 2026: $319.9M
Q1 2021Q2 2026
13F filings of JW Asset Management, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 7, 202621$319.9MESTASNDKCOCOvs. Q1 2026SEC
Q1 2026May 8, 202619$243.5MESTACOCOCPRXvs. Q4 2025SEC
Q4 2025Feb 6, 202618$307.2MESTACOCOHOODvs. Q3 2025SEC
Q3 2025Nov 7, 202517$208.4MESTAMETAHOODvs. Q2 2025SEC
Q2 2025Aug 11, 202519$202.9MESTAMETAHOODvs. Q1 2025SEC
Q1 2025May 9, 202518$176.6MESTACPRXCOCOvs. Q4 2024SEC
Q4 2024Feb 7, 202517$210.4MESTANVDACOCOvs. Q3 2024SEC
Q3 2024Nov 8, 202413$221.5MESTANVDAANFvs. Q2 2024SEC
Q2 2024Aug 8, 202413$242.7MESTANVDAANFvs. Q1 2024SEC
Q1 2024May 7, 202414$273.7MESTACELHNVDAvs. Q4 2023SEC
Q4 2023Feb 9, 202417$175.2MESTACELHLLYvs. Q3 2023SEC
Q3 2023Nov 9, 202315$230.9MESTACELHLLYvs. Q2 2023SEC
Q2 2023Aug 11, 202310$274.8MESTACELHLLYvs. Q1 2023SEC
Q1 2023May 5, 20238$260.6MESTANVOCPRXvs. Q4 2022SEC
Q4 2022Feb 10, 20238$243.1MESTACPRXCELHvs. Q3 2022SEC
Q3 2022Nov 14, 20229$185.7MESTACELHHZNPvs. Q2 2022SEC
Q2 2022Aug 12, 20228$183.3MESTAHZNPIDRvs. Q1 2022SEC
Q1 2022Aug 12, 2022Amended9$290.3MESTAAMZNTSLAvs. Q4 2021SEC
Q4 2021Feb 11, 20227$301.8MESTAAMZNHZNPvs. Q3 2021SEC
Q3 2021Nov 5, 20219$331.6MESTAAMZNGRWGvs. Q2 2021SEC
Q2 2021Aug 6, 202110$427.5MESTAAMZNGRWGvs. Q1 2021SEC
Q1 2021May 14, 202110$347.6MESTAAMZNGRWG–SEC

13D and 13G filings

Companies where JW Asset Management, LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

2 companies, largest stake first.

Companies where JW Asset Management, LLC owns 5% or more
CompanyLatest formStakeChangeFirst filedLatest filingFiling
TSNDFTerrAscend Corp.13D/A29.54%93.8M shares−4.20 ppfrom 33.74%Feb 14, 20227 filingsAug 27, 2025SEC
ESTAEstablishment Labs Holdings Inc.13G9.15%2.69M sharesNewJul 31, 20261 filingJul 31, 2026SEC

Latest filings

8 filings on file made by JW Asset Management, LLC or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by JW Asset Management, LLC
CompanyFiled (ET)FormStakeChangeEvent dateFiling
ESTAEstablishment Labs Holdings Inc.Jul 31, 20265:00 PM ET13G9.15%2.69M sharesNewJun 30, 2026SEC
TSNDFTerrAscend Corp.Aug 27, 20254:31 PM ET13D/A29.54%93.8M shares−4.20 ppfrom 33.74%Aug 27, 2025SEC
TSNDFTerrAscend Corp.Dec 19, 20244:02 PM ET13D/A33.74%102.5M shares–Dec 17, 2024SEC
TSNDFTerrAscend Corp.Jan 2, 202413D/AOld format–––SEC
TSNDFTerrAscend Corp.May 31, 202313D/AOld format–––SEC
TSNDFTerrAscend Corp.Dec 28, 202213D/AOld format–––SEC
TSNDFTerrAscend Corp.Mar 17, 202213DOld format–––SEC
TSNDFTerrAscend Corp.Feb 14, 202213GOld format–New–SEC